Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Growth 2022-2028

February 2022 | 71 pages | ID: GE09A800B448EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Latisse (Bimatoprost) ( CAS 155206-00-1) will have significant change from previous year. According to our (LP Information) latest study, the global Latisse (Bimatoprost) ( CAS 155206-00-1) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Latisse (Bimatoprost) ( CAS 155206-00-1) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Latisse (Bimatoprost) ( CAS 155206-00-1) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Latisse (Bimatoprost) ( CAS 155206-00-1) market, reaching US$ million by the year 2028. As for the Europe Latisse (Bimatoprost) ( CAS 155206-00-1) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Latisse (Bimatoprost) ( CAS 155206-00-1) players cover Allergan plc (AbbVie Inc.), Sandoz(Novartis), Hi-Tech Pharmacal, and Apotex Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Latisse (Bimatoprost) ( CAS 155206-00-1) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

• Medicine Grade
• Cosmetic Grade

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

• Medicine
• Cosmetic
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

• Allergan plc (AbbVie Inc.)
• Sandoz(Novartis)
• Hi-Tech Pharmacal
• Apotex Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Latisse (Bimatoprost) ( CAS 155206-00-1) by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Latisse (Bimatoprost) ( CAS 155206-00-1) by Country/Region, 2017, 2022 & 2028
2.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Segment by Type
  2.2.1 Medicine Grade
  2.2.2 Cosmetic Grade
2.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type
  2.3.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2017-2022)
  2.3.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sale Price by Type (2017-2022)
2.4 Latisse (Bimatoprost) ( CAS 155206-00-1) Segment by Application
  2.4.1 Medicine
  2.4.2 Cosmetic
  2.4.3 Others
2.5 Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application
  2.5.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sale Market Share by Application (2017-2022)
  2.5.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sale Price by Application (2017-2022)

3 GLOBAL LATISSE (BIMATOPROST) ( CAS 155206-00-1) BY COMPANY

3.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Breakdown Data by Company
  3.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Sales by Company (2020-2022)
  3.1.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2020-2022)
3.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Revenue by Company (2020-2022)
  3.2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Company (2020-2022)
  3.2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Company (2020-2022)
3.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sale Price by Company
3.4 Key Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Product Location Distribution
  3.4.2 Players Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR LATISSE (BIMATOPROST) ( CAS 155206-00-1) BY GEOGRAPHIC REGION

4.1 World Historic Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size by Geographic Region (2017-2022)
  4.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Revenue by Geographic Region
4.2 World Historic Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size by Country/Region (2017-2022)
  4.2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Revenue by Country/Region
4.3 Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth
4.4 APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth
4.5 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth
4.6 Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth

5 AMERICAS

5.1 Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country
  5.1.1 Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2017-2022)
  5.1.2 Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2017-2022)
5.2 Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type
5.3 Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Region
  6.1.1 APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Region (2017-2022)
  6.1.2 APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Region (2017-2022)
6.2 APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type
6.3 APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) by Country
  7.1.1 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2017-2022)
  7.1.2 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2017-2022)
7.2 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type
7.3 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) by Country
  8.1.1 Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2017-2022)
8.2 Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type
8.3 Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Latisse (Bimatoprost) ( CAS 155206-00-1)
10.3 Manufacturing Process Analysis of Latisse (Bimatoprost) ( CAS 155206-00-1)
10.4 Industry Chain Structure of Latisse (Bimatoprost) ( CAS 155206-00-1)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Distributors
11.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Customer

12 WORLD FORECAST REVIEW FOR LATISSE (BIMATOPROST) ( CAS 155206-00-1) BY GEOGRAPHIC REGION

12.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Forecast by Region
  12.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Forecast by Region (2023-2028)
  12.1.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Forecast by Type
12.7 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Allergan plc (AbbVie Inc.)
  13.1.1 Allergan plc (AbbVie Inc.) Company Information
  13.1.2 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offered
  13.1.3 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Allergan plc (AbbVie Inc.) Main Business Overview
  13.1.5 Allergan plc (AbbVie Inc.) Latest Developments
13.2 Sandoz(Novartis)
  13.2.1 Sandoz(Novartis) Company Information
  13.2.2 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offered
  13.2.3 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Sandoz(Novartis) Main Business Overview
  13.2.5 Sandoz(Novartis) Latest Developments
13.3 Hi-Tech Pharmacal
  13.3.1 Hi-Tech Pharmacal Company Information
  13.3.2 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offered
  13.3.3 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Hi-Tech Pharmacal Main Business Overview
  13.3.5 Hi-Tech Pharmacal Latest Developments
13.4 Apotex Inc.
  13.4.1 Apotex Inc. Company Information
  13.4.2 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offered
  13.4.3 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Apotex Inc. Main Business Overview
  13.4.5 Apotex Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Latisse (Bimatoprost) ( CAS 155206-00-1) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Medicine Grade
Table 4. Major Players of Cosmetic Grade
Table 5. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type (2017-2022) & (Kiloton)
Table 6. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2017-2022)
Table 7. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Type (2017-2022)
Table 9. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sale Price by Type (2017-2022) & (US$/Ton)
Table 10. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application (2017-2022) & (Kiloton)
Table 11. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2017-2022)
Table 12. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Application (2017-2022)
Table 13. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Application (2017-2022)
Table 14. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sale Price by Application (2017-2022) & (US$/Ton)
Table 15. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Company (2020-2022) & (Kiloton)
Table 16. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Company (2020-2022)
Table 17. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Company (2020-2022)
Table 19. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sale Price by Company (2020-2022) & (US$/Ton)
Table 20. Key Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Producing Area Distribution and Sales Area
Table 21. Players Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
Table 22. Latisse (Bimatoprost) ( CAS 155206-00-1) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Geographic Region (2017-2022) & (Kiloton)
Table 26. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country/Region (2017-2022) & (Kiloton)
Table 30. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2017-2022) & (Kiloton)
Table 34. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country (2017-2022)
Table 35. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country (2017-2022)
Table 37. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type (2017-2022) & (Kiloton)
Table 38. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2017-2022)
Table 39. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application (2017-2022) & (Kiloton)
Table 40. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2017-2022)
Table 41. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Region (2017-2022) & (Kiloton)
Table 42. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Region (2017-2022)
Table 43. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Region (2017-2022)
Table 45. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type (2017-2022) & (Kiloton)
Table 46. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2017-2022)
Table 47. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application (2017-2022) & (Kiloton)
Table 48. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2017-2022)
Table 49. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2017-2022) & (Kiloton)
Table 50. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country (2017-2022)
Table 51. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country (2017-2022)
Table 53. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type (2017-2022) & (Kiloton)
Table 54. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2017-2022)
Table 55. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application (2017-2022) & (Kiloton)
Table 56. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2017-2022) & (Kiloton)
Table 58. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type (2017-2022) & (Kiloton)
Table 62. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application (2017-2022) & (Kiloton)
Table 64. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Latisse (Bimatoprost) ( CAS 155206-00-1)
Table 66. Key Market Challenges & Risks of Latisse (Bimatoprost) ( CAS 155206-00-1)
Table 67. Key Industry Trends of Latisse (Bimatoprost) ( CAS 155206-00-1)
Table 68. Latisse (Bimatoprost) ( CAS 155206-00-1) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Latisse (Bimatoprost) ( CAS 155206-00-1) Distributors List
Table 71. Latisse (Bimatoprost) ( CAS 155206-00-1) Customer List
Table 72. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Region (2023-2028) & (Kiloton)
Table 73. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Forecast by Region
Table 74. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Country (2023-2028) & (Kiloton)
Table 77. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Region (2023-2028) & (Kiloton)
Table 79. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Country (2023-2028) & (Kiloton)
Table 81. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Country (2023-2028) & (Kiloton)
Table 83. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Type (2023-2028) & (Kiloton)
Table 85. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Application (2023-2028) & (Kiloton)
Table 89. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Allergan plc (AbbVie Inc.) Basic Information, Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturing Base, Sales Area and Its Competitors
Table 93. Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offered
Table 94. Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 95. Allergan plc (AbbVie Inc.) Main Business
Table 96. Allergan plc (AbbVie Inc.) Latest Developments
Table 97. Sandoz(Novartis) Basic Information, Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturing Base, Sales Area and Its Competitors
Table 98. Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offered
Table 99. Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 100. Sandoz(Novartis) Main Business
Table 101. Sandoz(Novartis) Latest Developments
Table 102. Hi-Tech Pharmacal Basic Information, Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturing Base, Sales Area and Its Competitors
Table 103. Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offered
Table 104. Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 105. Hi-Tech Pharmacal Main Business
Table 106. Hi-Tech Pharmacal Latest Developments
Table 107. Apotex Inc. Basic Information, Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturing Base, Sales Area and Its Competitors
Table 108. Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offered
Table 109. Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 110. Apotex Inc. Main Business
Table 111. Apotex Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Latisse (Bimatoprost) ( CAS 155206-00-1)
Figure 2. Latisse (Bimatoprost) ( CAS 155206-00-1) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate 2017-2028 (Kiloton)
Figure 7. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Medicine Grade
Figure 10. Product Picture of Cosmetic Grade
Figure 11. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2021
Figure 12. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Type (2017-2022)
Figure 13. Latisse (Bimatoprost) ( CAS 155206-00-1) Consumed in Medicine
Figure 14. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market: Medicine (2017-2022) & (Kiloton)
Figure 15. Latisse (Bimatoprost) ( CAS 155206-00-1) Consumed in Cosmetic
Figure 16. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market: Cosmetic (2017-2022) & (Kiloton)
Figure 17. Latisse (Bimatoprost) ( CAS 155206-00-1) Consumed in Others
Figure 18. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market: Others (2017-2022) & (Kiloton)
Figure 19. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2017-2022)
Figure 20. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Application in 2021
Figure 21. Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Company in 2021
Figure 23. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Geographic Region in 2021
Figure 25. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Region (2017-2022)
Figure 26. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country/Region in 2021
Figure 27. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales 2017-2022 (Kiloton)
Figure 28. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue 2017-2022 ($ Millions)
Figure 29. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales 2017-2022 (Kiloton)
Figure 30. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue 2017-2022 ($ Millions)
Figure 31. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales 2017-2022 (Kiloton)
Figure 32. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales 2017-2022 (Kiloton)
Figure 34. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue 2017-2022 ($ Millions)
Figure 35. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country in 2021
Figure 36. Americas Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country in 2021
Figure 37. United States Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Region in 2021
Figure 42. APAC Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Regions in 2021
Figure 43. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country in 2021
Figure 50. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country in 2021
Figure 51. Germany Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country in 2021
Figure 58. Egypt Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Latisse (Bimatoprost) ( CAS 155206-00-1) in 2021
Figure 64. Manufacturing Process Analysis of Latisse (Bimatoprost) ( CAS 155206-00-1)
Figure 65. Industry Chain Structure of Latisse (Bimatoprost) ( CAS 155206-00-1)
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles